A possible role of neuropeptide Y in depression and stress

被引:177
作者
Morales-Medina, Julio Cesar [1 ,2 ]
Dumont, Yvan [1 ]
Quirion, Remi [1 ,3 ]
机构
[1] McGill Univ, Douglas Mental Hlth Univ Inst, Montreal, PQ H4H 1R3, Canada
[2] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H4H 1R3, Canada
[3] McGill Univ, Dept Psychiat, Montreal, PQ H4H 1R3, Canada
基金
加拿大健康研究院;
关键词
Animal model; Antidepressant; Depression; Neuropeptide Y; Stress; Mood disorder; CORTICOTROPIN-RELEASING-FACTOR; MESSENGER-RNA EXPRESSION; YY2 RECEPTOR ANTAGONIST; FORCED SWIM TEST; MICE LACKING; PANCREATIC-POLYPEPTIDE; MAJOR DEPRESSION; PEPTIDE-YY; FOOD-INTAKE; MATERNAL SEPARATION;
D O I
10.1016/j.brainres.2009.09.077
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neuropeptide Y (NPY) mediates its physiological effects through at least four receptors known as Y-1, Y-2, Y-4, and Y-5. This peptide is one of the most abundant peptides in the central nervous system and is highly conserved throughout evolution. The most abundant receptors of the NPY family, the Y-1 and Y-2 receptors, are densely expressed in the cortex, hippocampus, and amygdala. These brain regions are particularly associated with mood disorders, stress responses, and memory processing. With this in mind, researchers suggested the involvement of NPY as well as the Y-1 and Y-2 receptors in affective disorders. Earlier studies showed that NPY and the Y-1 and Y-2 receptors mediate some aspects of depression-like disorders and stress responses in rodents. Recent research also suggests the involvement of the Y-4 and Y-5 receptors in emotion-related processes in rodents. In addition, human studies have consistently suggested a role for NPY in stress responses, whereas conflicting data have been obtained in relation to the role of NPY in depression-related illnesses. However, novel evidence from polymorphisms in the prepro-NPY gene has shed new light on the potential clinical relevance of NPY in depression. In this article, we review the literature from both animal and human studies regarding the contribution of NPY and its receptors in depression and stress. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:194 / 205
页数:12
相关论文
共 127 条
[1]   Neuropeptide Y promotes sleep and inhibits ACTH and cortisol release in young men [J].
Antonijevic, IA ;
Murck, H ;
Bohlhalter, S ;
Frieboes, RM ;
Holsboer, F ;
Steiger, A .
NEUROPHARMACOLOGY, 2000, 39 (08) :1474-1481
[2]  
APA, 1994, DIAG STAT MAN MENT D
[3]   Mouse pancreatic polypeptide modulates food intake, while not influencing anxiety in mice [J].
Asakawa, A ;
Inui, A ;
Ueno, N ;
Fujimiya, M ;
Fujino, MA ;
Kasuga, M .
PEPTIDES, 1999, 20 (12) :1445-1448
[4]   Characterization of the effects of pancreatic polypeptide in the regulation of energy balance [J].
Asakawa, A ;
Inui, A ;
Yuzuriha, H ;
Ueno, N ;
Katsuura, G ;
Fujimiya, M ;
Fujino, MA ;
Niijima, A ;
Meguid, MM ;
Kasuga, M .
GASTROENTEROLOGY, 2003, 124 (05) :1325-1336
[5]   Behavioral characterization of neuropeptide Y knockout mice [J].
Bannon, AW ;
Seda, J ;
Carmouche, M ;
Francis, JM ;
Norman, MH ;
Karbon, B ;
McCaleb, ML .
BRAIN RESEARCH, 2000, 868 (01) :79-87
[6]   Current trends in the assessment and somatic treatment of resistant/refractory major depression: An overview [J].
Berlim, Marcelo T. ;
Fleck, Marcelo P. ;
Turecki, Gustavo .
ANNALS OF MEDICINE, 2008, 40 (02) :149-159
[7]   Neuropeptide YY1 and Y2 receptor mRNA expression in the prefrontal cortex of psychiatric subjects -: Relationship of Y2 subtype to suicidal behavior [J].
Caberlotto, L ;
Hurd, YL .
NEUROPSYCHOPHARMACOLOGY, 2001, 25 (01) :91-97
[8]   Alterations in neuropeptide Y levels and Y1 binding sites in the Flinders Sensitive Line rats, a genetic animal model of depression [J].
Caberlotto, L ;
Jimenez, P ;
Overstreet, DH ;
Hurd, YL ;
Mathé, AA ;
Fuxe, K .
NEUROSCIENCE LETTERS, 1999, 265 (03) :191-194
[9]   Reduced neuropeptide Y mRNA expression in the prefrontal cortex of subjects with bipolar disorder [J].
Caberlotto, L ;
Hurd, YL .
NEUROREPORT, 1999, 10 (08) :1747-1750
[10]   Stress, depression and the mesolimbic dopamine system [J].
Cabib, S ;
PuglisiAllegra, S .
PSYCHOPHARMACOLOGY, 1996, 128 (04) :331-342